Connect with us

Technology

GSK Leverages Genedata Biologics as End-to-End Automation and Data Science Platform

Published

on

Global biopharma leader drives digital innovation, data sciences, and next-generation automation approaches with Genedata’s cloud-based Biopharma Platform

BASEL, Switzerland, July 31, 2024 /PRNewswire-PRWeb/ — Genedata, a leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that GSK, a leading biopharma company, has extended the use of Genedata Biologics® to new application areas in data sciences, analytics, and R&D automation.

Access to structured and organized data from Genedata Biologics enables our data science, predictive modelling, and AI/ML projects as we continue our work to optimize the clinical effectiveness of our medicines. Steve Martin, Ph.D., VP and Head of Large Molecule Discovery at GSK

“We’ve migrated our on-premise hosted version of Biologics to Genedata’s SaaS platform to leverage the various benefits that cloud-hosting offers. We continue to integrate data workflows for design, production, screening, characterization and engineering of novel biotherapeutics whilst developing features to handle bi- and multi-specific modalities,” said Steve Martin, Ph.D., VP and Head of Large Molecule Discovery. “At GSK we use leading edge data and platform technologies to discover and develop new medicines and vaccines better and faster to positively impact the health of people at scale. Access to structured and organized data from Genedata Biologics enables our data science, predictive modelling, and AI/ML projects as we continue our work to optimize the clinical effectiveness of our medicines.”

Since its initial deployment in 2013, Genedata Biologics has become a core part of GSK’s Large Molecule Discovery team’s antibody discovery data platform, automating lab operations and data streams from diverse discovery projects. Genedata Biologics directly integrates with GSK’s automation systems to generate, express, and purify large numbers of candidates, followed by high-throughput characterization and lead evaluation. Automated cloning and expression runs generate a substantial number of data and metadata points that Genedata Biologics can store and help cascade to downstream consumers across the organization.

The system offers real-time access to all critical data to GSK’s scientists, managers, and executives, which promotes synergies within and across projects. The Genedata platform also enables users across R&D to monitor program performance, resource and project planning, and task prioritization.

“We are pleased that GSK, one of the leading innovators in the development of novel biopharmaceuticals, has decided to expand the use of Genedata Biologics as their foundation platform for guided biotherapeutics discovery,” said Othmar Pfannes, Ph.D., CEO of Genedata. “Digital transformation is opening new horizons in biopharmaceutical R&D, and we are excited that our platform is helping GSK to develop innovative biotherapies faster.”

About Genedata
Genedata transforms data into intelligence with innovative software solutions that incorporate extensive biopharma R&D domain knowledge. Multinational biopharmaceutical organizations and cutting-edge biotechs around the globe rely on Genedata to digitalize and automate data-rich and complex R&D processes. From early discovery all the way to the clinic, Genedata solutions help maximize the ROI in R&D expenditure. Founded in 1997, Genedata is headquartered in Basel, Switzerland with additional offices in Boston, London, Munich, San Francisco, Singapore, and Tokyo.
http://www.genedata.com
LinkedIn | X | YouTube

Contact 
Allison Kurz
Genedata
Public Relations
pr@genedata.com

Disclaimer
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company’s products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.

Media Contact

Allison Kurz, Genedata, +41 61 511 84 00, pr@genedata.com, www.genedata.com

View original content to download multimedia:https://www.prweb.com/releases/gsk-leverages-genedata-biologics-as-end-to-end-automation-and-data-science-platform-302207516.html

SOURCE Genedata

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Ant Digital Technologies CTO: The Agent Economy’s Four Fault Lines Demand a Ground-Up Infrastructure Redesign

Published

on

By

HONG KONG, April 21, 2026 /PRNewswire/ — On April 20, Ant Digital Technologies introduced its architectural vision for the agent economy at Hong Kong Web3 Festival — the “4R Full-Stack Architecture,” comprising four layers: Agentic Runtime, Payment Rails, Agent Registry, and Root Infrastructure — aimed at providing AI agents with foundational technical infrastructure covering identity, payments, risk control, and regulatory compliance.

In her keynote, Dr. Yan Ying, CTO of Ant Digital Technologies identified four fundamental fault lines in the current foundations of the agent economy: execution failures arising from prompt logic vulnerabilities, an accountability vacuum caused by AI’s lack of verifiable identity, transactional barriers stemming from payment gateways designed around human principals, and collaboration risks that emerge when unfamiliar agents cannot establish mutual trust. “This cannot be resolved by patching software,” she stated. “It requires a ground-up redesign at the infrastructure layer.”

The core product of the Agentic Runtime layer is DT Claw, which embeds the CARLI safety model to enforce behavioral constraints on agents at the execution level, supports multi-model compatibility and financial-grade compliance standards, and is designed to ensure that every AI operation is controllable, auditable, and recoverable.

The Payment Rails layer establishes a native on-chain payment channel that integrates agent-driven intelligent decision-making with verifiable credential chain technology, enabling precise identification of payment intent and end-to-end security while delivering full transaction transparency and immutability. For high-frequency micropayment scenarios, the platform builds a native instant settlement network supporting cross-chain, multi-asset seamless transfer and intelligent routing, significantly improving capital turnover efficiency. Additionally, by providing a standardized developer toolchain and a frictionless wallet integration experience, the solution substantially lowers both development barriers and end-user adoption costs — forming a payment closed-loop that balances financial-grade security with best-in-class usability.

The Agent Registry layer issues on-chain identities to each agent based on the DID (Decentralized Identifier) standard and ERC-8004, ensuring every instance of inter-agent collaboration is traceable and verifiable. The Root Infrastructure layer serves as the architectural foundation, leveraging Jovay Layer2 to achieve sub-120-millisecond transaction confirmation in support of AI micropayments, and combining ZKVM technology to enable off-chain computation with on-chain verification — resolving the computational trust problem inherent in the AI economy. As Yan Ying put it, “Root Infrastructure uses blockchain and privacy-preserving computation to provide agents with a tamper-proof contract execution environment. Even two agents with no prior relationship can establish trust through code and transact with confidence.”

AI is currently progressing from the Chat phase through the Action phase and into the era of the agent economy. Yan Ying argued that the defining transformation of this third phase lies not in AI becoming more intelligent, but in AI beginning to hold assets and exercise transactional authority. She noted that over the past decade-plus, Ant Digital Technologies has accumulated deep engineering expertise across financial-grade security, privacy computing, blockchain, and compliance systems — and that the 4R Architecture represents a ground-up research and development effort built upon that foundation.

 

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/ant-digital-technologies-cto-the-agent-economys-four-fault-lines-demand-a-ground-up-infrastructure-redesign-302748251.html

SOURCE Ant Digital Technologies

Continue Reading

Technology

Candid Appoints Andrew Shaw as Chief Product & Technology Officer to Accelerate Platform Growth

Published

on

By

Seasoned product leader joins from OLX to scale Candid’s Live Marketing™ AI infrastructure across the UK and beyond

LONDON and AMSTERDAM, April 21, 2026 /PRNewswire/ — Candid, the platform-based advertising, marketing and communications group operating across the Netherlands and the United Kingdom, has today appointed Andrew Shaw as Chief Product & Technology Officer (CPTO), effective immediately.

Working at group level, Shaw assumes responsibility for Candid’s product strategy, technology infrastructure and the scaling of its agency brands and capabilities. His appointment comes at a pivotal moment for the group, with strong and growing market demand for Candid’s proprietary Live Marketing™ platform — an integrated, AI-powered infrastructure spanning strategy, campaigns, media and creative. Shaw’s immediate mandate is to accelerate its development and bring it to enterprise scale.

Shaw joins with a strong international pedigree in product leadership and technology innovation. He was most recently Director of Product at OLX in Amsterdam, and prior to that held a comparable senior product role at adidas in Germany. Originally from South Africa, Shaw spent over five years in Germany before relocating to the Netherlands four years ago, where he has built deep expertise working within complex, international technology organisations.

In his new role, Shaw will work across Candid’s group of agencies and brands — building the product and technology foundations that underpin the group’s client proposition and ensuring the Candid platform maintains its competitive edge in a fast-evolving market.

Andrew Shaw, Chief Product & Technology Officer, Candid:

“My remit is clear: to take Candid’s Live Marketing™ infrastructure from proven technology to a truly differentiated, enterprise-grade and scalable platform — one that holds its competitive advantage in a market that is moving fast.”

Gerard Ghazarian, Founder & President, Candid:

“Andrew brings exactly the depth of product and technology leadership that this moment calls for. He will be instrumental in shaping our product strategy and in building the technology organisation we need to realise our ambitions — in the UK, the Netherlands, and beyond.”

Shaw’s appointment represents a significant step in Candid’s continued investment in its technology capabilities and leadership team. As the group scales across its agency brands and geographies, this appointment signals an unambiguous commitment to building a robust, future-proof platform that delivers tangible, measurable value for clients and brand partners across the portfolio.

Photo – https://mma.prnewswire.com/media/2960657/Candid.jpg

View original content:https://www.prnewswire.co.uk/news-releases/candid-appoints-andrew-shaw-as-chief-product–technology-officer-to-accelerate-platform-growth-302747667.html

Continue Reading

Technology

NX Group to Acquire All Shares in Metro Supply Chain Group of Canada, Turning It into Subsidiary

Published

on

By

TOKYO, April 21, 2026 /CNW/ — NIPPON EXPRESS HOLDINGS, INC. (hereafter “NX Group”) has reached an agreement to acquire all shares in Metro Supply Chain Group Inc. (“Metro Supply Chain Group”) based in Montreal, Canada, and entered into a share purchase agreement, dated April 17, 2026.

Logo: https://drive.google.com/file/d/1dqm0cxpYamnvMUra1AGXMuGlX932Z353/view?usp=drive_link 

The transaction values Metro Supply Chain Group at CAD1.8 billion (approximately 207.0 billion yen) on an enterprise value basis, representing the largest acquisition in NX Group’s history. In addition, an earnout of up to CAD400 million (approximately 46.0 billion yen) may be payable to the sellers, contingent on the company meeting certain financial targets as defined in the share purchase agreement.

Metro Supply Chain Group has a strong operational footprint across Canada, the United States and the United Kingdom, providing third-party logistics (3PL) services to a broad range of industries, including consumer goods, automotive, manufacturing and healthcare. Through this acquisition, NX Group expects to significantly expand its presence in the North American market and enhance its end-to-end logistics capabilities. The transaction represents a pivotal step toward accelerating NX Group’s long-term vision — set out in its management plan “NX Group Management Plan 2028 Dynamic Growth 2.0” — of becoming “a logistics company with a strong presence in global markets.”

For more details, please visit: https://drive.google.com/file/d/1SvzqxdP0zEEDCtmm2yhpGjBuDkM3iJea/view?usp=drive_link 

About the NX Group: https://drive.google.com/file/d/1mbvBL6C8THZNrR5LREgGeafNkEdaAmV-/view?usp=drive_link 

NX Group official website: https://www.nipponexpress.com/ 

NX Group’s official LinkedIn account: https://www.linkedin.com/company/nippon-express-group/ 

 

View original content:https://www.prnewswire.com/news-releases/nx-group-to-acquire-all-shares-in-metro-supply-chain-group-of-canada-turning-it-into-subsidiary-302747977.html

SOURCE NIPPON EXPRESS HOLDINGS, INC.

Continue Reading

Trending